Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
Status:
Withdrawn
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is a double-masked, randomized, parallel group study in patients with open angle
glaucoma or ocular hypertension.
The aim of this study is to verify the efficacy of the fixed combination of Latanoprost 50
mcg / mL / brinzolamide 10mg/ml eye drops compared to Latanoprost 50μg/mL eye drops in
reducing IOP